dRAST™ allows rapid and direct antibiotic sensitivity testing from positive blood cultures, enabling therapy to be optimised for the critical treatment of sepsis.

  • Direct: Phenotypic assessment of antimicrobial susceptibility directly from a positive blood culture.
  • Rapid: Results for 12 samples in only 4-6 hours, saving up to 48 hours compared to conventional antibiograms.
  • Simple: Intuitive and easy to use interface.
  • Comprehensive solution: Antibiogram, analysis and interpretation of results (MIC and SIR classification).
  • Integrated analysis software “dRAST Expert System”, which allows the incorporation of international guidelines and recommendations (EUCAST, CLSI and CA-SFM).
image 28

After a simple Gram stain, positive blood culture samples are loaded into the dRAST™ platform without any additional preparation, along with consumables and antibiotic panels for Gram-negative or Gram-positive bacteria, depending on the results of the initial staining.

image 30

dRAST™ combines 2 reference methods (broth microdilution and drug diffusion), with a patented system for time-lapse microscopic imaging.

  • dRASTcarrusel1
  • dRASTcarrusel2
  • dRASTcarrusel3
  • dRASTcarrusel4
  • dRASTcarrusel5

Area:

CMI Quick Sepsis, Microbiology

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Sepsis Pathogenic Microorganism Detection Kit (Digital PCR)

In vitro diagnostic kit based on droplet digital PCR (dPCR) for the detection of pathogenic microorganisms associated with sepsis from DNA extracted from clinical samples. The kit allows identification and quantification of pathogens without requiring blood culture, covering 21 frequent agents in bloodstream infections. Detailed Description Principle of operation The Sepsis Pathogenic Microorganism Detection Kit…
RainSure
Digital PCR

VIASURE 16S V1-V4 NGS Solution

NGS solution for library preparation aimed at the simultaneous identification and profiling of microbial species present in DNA extracted from original samples, through the analysis of the variable regions V1-V4 of the 16S rRNA gene. Product for research use only (RUO) and not intended for diagnostic procedures. Detailed Description Principle of operation VIASURE 16S V1-V4…
Certest
Next Generation Sequencing (NGS)

PN-900 CandidaGenius® C. auris screening assay

Real‑time PCR assay for the rapid and direct detection of Candida auris from non‑invasive swabs, without the need for prior culture. Detailed Description The PN-900 CandidaGenius® C. auris screening assay is a molecular tool designed for the qualitative detection of Candida auris DNA by real‑time PCR. This emerging fungus represents a growing challenge in the…
Pathonostics
Real Time PCR (qPCR)

Illumina Viral Surveillance Panel v2

Next‑generation sequencing (NGS) assay with hybrid capture enrichment for the detection and whole‑genome sequencing of approximately 200 RNA and DNA viruses relevant to public health. It integrates library preparation, enrichment, sequencing, and data analysis into an optimized workflow of about two days. Detailed Description Principle of operation The panel can start from RNA, DNA, or…
Illumina
Next Generation Sequencing (NGS)